Women's Health

While pharmacotherapy makes strides in the treatment of rheumatoid arthritis, experts must recognize how other factors in a patient’s life can affect his or her disease.

Women with osteoporosis are not being identified and treated at sufficient rates, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

Research in HF, omega-3 fatty acids, cardiac imaging among women and drug-eluting stents are among the topics of late-breaking clinical trials being presented at the virtual American Heart Association Scientific Sessions.

September is Gynecologic Cancer Awareness Month, an awareness campaign launched in 1999 by Foundation for Women’s Cancer.

Women hospitalized with acute MI and cardiogenic shock may undergo less aggressive treatment and have higher rates of in-hospital mortality compared with men, researchers reported.

Omega-3 polyunsaturated fatty acids appeared to have a small but significant beneficial effect on perinatal depression, according to results of a meta-analysis published in Journal of Clinical Psychiatry.

Awareness on the leading cause of death in women — heart disease — declined from 2009 to 2019, particularly in non-Hispanic Black and Hispanic women, and in younger women, an American Heart Association survey found.

Adverse pregnancy outcomes, particularly hypertensive disorders of pregnancy and low birth weight, were independently linked to atherosclerotic CVD in postmenopausal women, researchers found.

Women with early-onset MI had fewer recurrent major CV events during long-term follow-up compared with men, despite sex differences regarding disease burden and preventive treatments, researchers found.

Emily Barrows, MD, is an assistant professor in the department of obstetrics and gynecology at Virginia Commonwealth University.